Description: Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Home Page: www.aspenpharma.com
Aspen Place
Durban,
South Africa
Phone:
27 31 580 8600
Officers
| Name | Title |
|---|---|
| Mr. Stephen Bradley Saad BCom, CA(SA) | Group CEO & Executive Director |
| Mr. Sean M. Capazorio | Group CFO & Executive Director |
| Ms. Lorraine Hill | Group Chief Operations Officer |
| Mr. Michael Guy Attridge B.Com., CA(SA) | Group Chief Advisor |
| Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corporate Officer & Executive Director |
| Ms. Zizipho Mmango | Group Chief Strategic Development Officer |
| Ms. Sibongakonke Nkosi | Investor Relations Manager |
| Ms. Raeesa Khan | Group Company Secretary & Chief of Staff |
| Mr. Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific |
| Mr. Samer Kassem | Chief Executive Officer of Aspen Global Incorporated |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 17.0192 |
| Price-to-Book MRQ: | 0.8846 |
| Price-to-Sales TTM: | 0.0882 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 8867 |